Editorial: Molecular Strategies Aimed to Boost NK Cell-Based Immunotherapy of Cancer.

Front Immunol

Cancer Research Center of Marseille, INSERM U1068, CNRS U7258, Aix-Marseille University, Institut Paoli-Calmettes, Marseille, France.

Published: April 2021

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7308425PMC
http://dx.doi.org/10.3389/fimmu.2020.01132DOI Listing

Publication Analysis

Top Keywords

editorial molecular
4
molecular strategies
4
strategies aimed
4
aimed boost
4
boost cell-based
4
cell-based immunotherapy
4
immunotherapy cancer
4
editorial
1
strategies
1
aimed
1

Similar Publications

Background: Rearranged during transfection () fusions represent a distinct molecular subset of non-small cell lung cancer (NSCLC) with targeted therapeutic potential. Selpercatinib, a highly selective inhibitor, has demonstrated efficacy in various solid tumors harboring alterations. Here, we present a case highlighting the use and clinical outcomes of selpercatinib in a patient diagnosed with advanced lung adenocarcinoma harboring a fusion.

View Article and Find Full Text PDF

Editorial: Community series in BCR signaling and B cell activation, volume 2.

Front Immunol

January 2025

State Key Laboratory of Membrane Biology, School of Life Sciences, Tsinghua-Peking Center for Life Sciences, Institute for Immunology, China Ministry of Education Key Laboratory of Protein Sciences, Beijing, China.

View Article and Find Full Text PDF

Introduction: Chronic fetal hypoxia is commonly associated with fetal growth restriction and can predispose to respiratory disease at birth and in later life. Antenatal antioxidant treatment has been investigated to overcome the effects of oxidative stress to improve respiratory outcomes. We aimed to determine if the effects of chronic fetal hypoxia and antenatal antioxidant administration persist in the lung in early adulthood.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!